<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190925044880N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-08</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The Effectiveness of Eye Movement Desensitization and Reprocessing Therapy on Anxiety and Pain</public_title>
      <acronym>EMDR</acronym>
      <scientific_title>The Effectiveness of Eye Movement Desensitization and Reprocessing Therapy on Anxiety and Pain Levels Experienced by Hospitalized Children After Undergoing Surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/42484</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: For random allocation of the samples, participants names are written on paper cards and then put in a box. ‎The names of participants are then randomly selected by the researcher. The first name drawn is assigned to the experimental group ‎and the second name is assigned to the control group, and so on until all of the cards are selected. In this way, ‎participants do not know whether they are in the experimental or control group.‎.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Children's Surgery.</hc_freetext>
      <i_freetext>Intervention 1: The Spielberger State-Trait Anxiety ‎Inventory(STAI) is administered to subjects before and after surgery, in both the experimental and control groups. Along with the STAI used for anxiety measures, a numerical pain rating scale is utilized to evaluate levels of pain.  In this experiment the patient will undergo EMDR therapy for one session, spanning from at least 30 minutes to up to 60 minutes. The patient will be asked to talk about his/her experiences with their illness and surgery; discussing their memories, worries and negative feelings related to these experiences. Subsequently, scores are obtained through two common methods of variable measurement associated with the practice of EDMR therapy. These methods include the Subjective Units of Disturbance (SUD) Scale, a numerical scale running from 1 through 10, commonly used in the practice of EDMR. The second mode of variable measurement is conducted through the Validity of Cognition (VOC) Scale, a numerical scale running from 1 through 7. These tests are administered to the patients via the researchers and the results are recorded. In the next phase of the experiment, the children are asked to imagine and describe somewhere they consider a safe place and that makes them feel most calm; this could include for example a beach, forest, their room, etc. The child is also asked to keep in mind his/her painful memories associated with all the unpleasant emotions regarding surgery and hospitalization that cause him or her distressing thoughts. At the same time, his/her eyes should be focused on the researcher's finger movements, this should result in them experiencing rapid eye movements synchronized with the movement of the researcher's finger. The treatment then switches focus to the child's positive beliefs and emotions, the child is encouraged through this therapy to replace their positive emotions with the negative beliefs they are harboring with them. This time, while visualizing and keeping the painful memory in mind, we ask the child to trust his/her positive beliefs, while simultaneously following the researcher's hand movements with his/her eyes. At the end of the treatment, we ask of the children to imagine themselves in that safe place they discussed at the beginning of the session. Following the completion of EDMR therapy, the VOC and SUD scores are once again recorded from the participants. The researchers then work with the children to navigate through their emotions, to relieve negative emotions they have been harboring, that are causing feelings of distress and helplessness. In addition, Spielberger Inventory and the numerical ‎pain rating scale are also once again administered and recorded, both immediately after treatment and one-hour post-treatment. Intervention 2: Control group: In the control group the Spielberger State-Trait Anxiety ‎Inventory(STAI) is initially administered to subjects at the beginning of the trial. The control group receives no intervention, other than being given a copy of the training booklet designed for them. The STAI is then administered and recorded two more times, the first and second hours post experiment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no other information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Afarin Ghanavatpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.36, Shahed Ave., Chaharbagh Bala Street., Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8163673338</zip>
        <telephone>+98 31 3667 1793</telephone>
        <email>a.ghanavatpoor@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afarin Ghanavatpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.36, Shahed Ave., Chaharbagh Bala Street., Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8163673338</zip>
        <telephone>+98 31 3667 1793</telephone>
        <email>a.ghanavatpoor@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being between the ages of 12 to 16 years old
Experiencing hospital admission and surgery for the first time
Being of sound mental health</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>16 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>No other non-pharmacological intervention to control pain and anxiety during research stages.
The subjects have not undergone eye surgery, maxillofacial surgery, and neurosurgery.
Absence of facial and facial nerves in a way that prevents eye movements.
history of hyperactivity, depression, severe anxiety disorders, psychosis, and other major psychiatric illnesses-
history of known chronic diseases such as disability, diabetes, heart disease, cancer
Lack of speech abnormalities in a way that prevents the child from providing information and communication.-
history of surgery
Being under severe stress due to education, parental loss, divorce, etc
taking anxiolytic and antidepressant drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The Spielberger State-Trait Anxiety ‎Inventory(STAI) is administered to subjects before and after surgery, in both the experimental and control groups. Along with the STAI used for anxiety measures, a numerical pain rating scale is utilized to evaluate levels of pain.  In this experiment the patient will undergo EMDR therapy for one session, spanning from at least 30 minutes to up to 60 minutes. The patient will be asked to talk about his/her experiences with their illness and surgery; discussing their memories, worries and negative feelings related to these experiences. Subsequently, scores are obtained through two common methods of variable measurement associated with the practice of EDMR therapy. These methods include the Subjective Units of Disturbance (SUD) Scale, a numerical scale running from 1 through 10, commonly used in the practice of EDMR. The second mode of variable measurement is conducted through the Validity of Cognition (VOC) Scale, a numerical scale running from 1 through 7. These tests are administered to the patients via the researchers and the results are recorded. In the next phase of the experiment, the children are asked to imagine and describe somewhere they consider a safe place and that makes them feel most calm; this could include for example a beach, forest, their room, etc. The child is also asked to keep in mind his/her painful memories associated with all the unpleasant emotions regarding surgery and hospitalization that cause him or her distressing thoughts. At the same time, his/her eyes should be focused on the researcher's finger movements, this should result in them experiencing rapid eye movements synchronized with the movement of the researcher's finger. The treatment then switches focus to the child's positive beliefs and emotions, the child is encouraged through this therapy to replace their positive emotions with the negative beliefs they are harboring with them. This time, while visualizing and keeping the painful memory in mind, we ask the child to trust his/her positive beliefs, while simultaneously following the researcher's hand movements with his/her eyes. At the end of the treatment, we ask of the children to imagine themselves in that safe place they discussed at the beginning of the session. Following the completion of EDMR therapy, the VOC and SUD scores are once again recorded from the participants. The researchers then work with the children to navigate through their emotions, to relieve negative emotions they have been harboring, that are causing feelings of distress and helplessness. In addition, Spielberger Inventory and the numerical ‎pain rating scale are also once again administered and recorded, both immediately after treatment and one-hour post-treatment.</i_keyword>
      <i_keyword>Control group: In the control group the Spielberger State-Trait Anxiety ‎Inventory(STAI) is initially administered to subjects at the beginning of the trial. The control group receives no intervention, other than being given a copy of the training booklet designed for them. The STAI is then administered and recorded two more times, the first and second hours post experiment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: Before Surgury,Before intervention, immediately and then one hour later. ‎. Method of measurement: Spielberger's State-Trait Anxiety  ‎.</prim_outcome>
      <prim_outcome>Pain. Timepoint: Before intervention, immediately and then one hour later. In the control group. Method of measurement: and numerical pain rating scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-22</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Building No.4, Isfahan University of Medical Science, Hezarjirib Ave, Isfahan Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
